James D. Crapo resigned as a director and chief executive officer of Omni Bio Pharmaceutical, Inc. effective August 31, 2012. The company's board of directors appointed Steven M. Bathgate, a director, to serve as interim chief executive officer of the company beginning August 31, 2012 until a successor is appointed.